Location: Dorado, Puerto Rico
CIK: 0001910456 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $267M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 1,580,841 | $66.47M | 24.9% | $36.34 | — | COM | N5749R100 |
| STOK | STOKE THERAPEUTICS INC | 5,187,191 | $57.21M | 21.5% | $7.94 | +54.8% | COM | 86150R107 |
| GHRS | GH RESEARCH PLC | 4,858,994 | $34.01M | 12.8% | $9.04 | -11.1% | ORDINARY SHARES | G3855L106 |
| CCCC | C4 THERAPEUTICS INC | 6,852,744 | $24.67M | 9.2% | $4.53 | +9.8% | COM STK | 12529R107 |
| ALLO | ALLOGENE THERAPEUTICS INC | 10,874,723 | $23.16M | 8.7% | $2.64 | -6.5% | COM | 019770106 |
| TCRX | TSCAN THERAPEUTICS INC | 5,357,347 | $16.29M | 6.1% | $2.72 | +66.3% | COM | 89854M101 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,257,795 | $15.32M | 5.7% | $16.54 | -13.1% | COM | 230031106 |
| KROS | KEROS THERAPEUTICS INC | 544,001 | $8.612M | 3.2% | $51.97 | 0.0% | COM | 492327101 |
| — | PASSAGE BIO INC | 9,256,953 | $5.25M | 2.0% | $1.03 | — | COM | 702712100 |
| — | ALLAKOS INC | 3,628,144 | $4.39M | 1.6% | $1.21 | — | COM | 01671P100 |
| UPB | UPSTREAM BIO INC | 240,042 | $3.946M | 1.5% | $22.33 | 0.0% | COM | 91678A107 |
| DTIL | PRECISION BIOSCIENCES INC | 766,051 | $2.919M | 1.1% | $7.30 | 0.0% | COM NEW | 74019P207 |
| IBIO | IBIO INC | 862,279 | $2.113M | 0.8% | $1.77 | +44.8% | CON NEW | 451033708 |
| CRBU | CARIBOU BIOSCIENCES INC | 680,189 | $1.082M | 0.4% | $2.05 | -1.8% | COM | 142038108 |
| — | VOR BIOPHARMA INC | 637,218 | $707K | 0.3% | $1.11 | — | COM | 929033108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 17,400 | $291K | 0.1% | $11.30 | — | SPONSORED ADS | 152309100 |
| NEUP | NEUPHORIA THERAPEUTICS INC | 45,806 | $157K | 0.1% | $3.53 | 0.0% | COM | 64136E102 |
| — | REPARE THERAPEUTICS INC | 79,176 | $104K | 0.0% | $1.31 | — | COM | 760273102 |